Compounded Solutions in Pharmacy, LLC

Form 483 issued August 29, 2019 · Monroe, Connecticut

Inspection
Aug 6 – Aug 29, 2019
Investigator
John P. Mistler
Observations
9
Pages
8
FEI number
3012039582

In short: On August 29, 2019, FDA issued a Form 483 with 9 observations to Compounded Solutions in Pharmacy, LLC in Monroe, Connecticut (FEI 3012039582) after an inspection that ran Aug 6 – Aug 29, 2019. The investigator was John P. Mistler. Most observations concern materials; the most-cited regulation is 21 CFR 211.80 (general requirements).

At a glance

Observations span 1 system, led by materials.

Materials1
Other8

Most cited: FDCA 501(a)(2)(A) (8×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    You used a non-pharmaceutical grade component in the formulation…

  2. 02
    FDCA 501(a)(2)(A)

    The ISO 5 classified aseptic processing areas had difficult to clean, particle-generating and visibly…

  3. 03
    FDCA 501(a)(2)(A)

    Non-microbial contamination was observed…

  4. 04
    FDCA 501(a)(2)(A)

    Unsealed, loose ceiling tiles were…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Compounded Solutions in Pharmacy, LLC?

FDA listed 9 observations on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.80 (general requirements). The opening words of each observation are shown on this page.

Who inspected Compounded Solutions in Pharmacy, LLC?

John P. Mistler is named on this Form 483, for the inspection of Aug 6 – Aug 29, 2019. Each investigator has a profile showing what they cite most.

When was Compounded Solutions in Pharmacy, LLC inspected by FDA?

The inspection ran Aug 6 – Aug 29, 2019, and the Form 483 is dated August 29, 2019.

How do I get the full Form 483 for Compounded Solutions in Pharmacy, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free